Review explores the bioactive compounds in ginger, highlighting its therapeutic potential and need for more research.
Ginger (Zingiber officinale) is a medicinal plant widely recognized for its phytochemical richness and therapeutic potential. This review consolidates evidence from peer-reviewed studies published between 2000 and 2026, focusing on its chemical constituents and pharmacological activities. Major bioactive compounds include gingerols, shogaols, paradols, and zingerone, which demonstrate antioxidant, anti-inflammatory, antimicrobial, antiemetic, anticancer, antidiabetic, cardioprotective, and neuroprotective effects. While preclinical studies provide strong support for these properties, the limited number of human clinical trials underscores the need for further research to validate its therapeutic applications.
No takes yet. Share an insight, caveat, or question.
Shosi Mari Larido1*, Sheryl Onganiza1, Diana Mae Cano1, Ruel Bardago1, Jesrel Mea Ebag1, Lyka Czarielle Faeldin1, Hazel Mae Sanches1, Kyle Christian Vreeland2 (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: